» Articles » PMID: 3631050

Detection of Hepatitis B Virus DNA in Asymptomatic Hepatitis B Surface Antigen Carriers: Relation to Sexual Transmission

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 1987 Oct 1
PMID 3631050
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The authors tested, by molecular hybridization, for hepatitis B virus DNA in serum specimens of 182 asymptomatic hepatitis B surface antigen (HBsAg) Greek carriers who were heterosexual partners of patients with acute hepatitis B (group A: 96 cases) or healthy subjects who were susceptible to hepatitis B (group B: 86 cases). The mean age (34.1 +/- 10.4 vs. 33.9 +/- 8.4 years) and the mean duration of sexual contact (6.9 +/- 8.9 vs. 7.2 +/- 6.3 years) were similar in the two groups of carriers. Hepatitis B virus DNA was detected significantly more frequently in group A than in group B (59.4% vs. 11.6%, p less than 0.001). In particular, in group A, hepatitis B virus DNA was detected in 96.9% of hepatitis B e antigen (HBeAg)-positive and 41% of antibody to HBeAg (anti-HBe)-positive carriers. In contrast, in group B, hepatitis B virus DNA was identified in only 10.8% of anti-HBe-positive carriers (p less than 0.001). These differences were especially significant in the young and middle-aged carriers (16-49 years old) and during the first four years of sexual contact. These data suggest that 1) there is a positive correlation between the presence of hepatitis B virus DNA in serum and the epidemiologic evidence of sexual transmission of hepatitis B virus, 2) hepatitis B virus DNA is a better indicator of infectivity than HBeAg/anti-HBe, and 3) the detection of hepatitis B virus DNA in serum probably identified carriers with high infectivity and potentially higher risk of transmitting hepatitis B virus to their sexual partners.

Citing Articles

Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma.

Kailasam Mani S, Andrisani O Cytokine. 2018; 124:154518.

PMID: 30126685 PMC: 6411443. DOI: 10.1016/j.cyto.2018.08.012.


Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Terrault N, Lok A, McMahon B, Chang K, Hwang J, Jonas M Hepatology. 2018; 67(4):1560-1599.

PMID: 29405329 PMC: 5975958. DOI: 10.1002/hep.29800.


Quantitative detection of hepatitis B virus DNA in sera from patients with acute hepatitis B.

Tassopoulos N, Kuhns M, Koutelou M, McNamara A, Todoulos A Dig Dis Sci. 1993; 38(12):2156-62.

PMID: 8261815 DOI: 10.1007/BF01299889.


Prevalence of hepatitis B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city state with intermediate HBV endemicity.

Heng B, Goh K, Chan R, Chew S, Doraisingham S, Quek G J Epidemiol Community Health. 1995; 49(3):309-13.

PMID: 7629470 PMC: 1060804. DOI: 10.1136/jech.49.3.309.


Serological markers of hepatitis B virus and hepatitis D virus infections in Greek adults with primary hepatocellular carcinoma.

Tassopoulos N, Theodoropoulos G, Sjogren M, Engle R, Purcell R Infection. 1989; 17(1):17-9.

PMID: 2537800 DOI: 10.1007/BF01643493.